Skip to main content

IN150 > Pill - white capsule/oblong

Pill with imprint IN150 > is White, Capsule/Oblong and has been identified as Ibandronate Sodium 150 mg (base). It is supplied by Watson Laboratories, Inc.

Ibandronate is used in the treatment of Prevention of Osteoporosis; Osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg (base) is not a controlled substance under the Controlled Substances Act (CSA).

Images for IN150 >

Ibandronate sodium 150 mg (base) IN150 >
Ibandronate sodium 150 mg (base) IN150 >
Ibandronate sodium 150 mg (base) IN150 >

Ibandronate Sodium

IN150 >
150 mg (base)
Prescription only
Drug Class
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Laboratories, Inc.
Inactive Ingredients
sorbitol, microcrystalline cellulose, silicon dioxide, croscarmellose sodium, sodium stearyl fumarate, titanium dioxide, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00591-3770 (Discontinued) Watson Pharmaceuticals, Inc.
42291-0336 (Discontinued) AvKare, Inc.

Get help with Imprint Code FAQs.

Related images for "IN150 >"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.